CJC no DAC / Ipamorelin

### **CJC-1295 (No DAC) / Ipamorelin Blend: Laboratory Research Overview** The CJC-1295 (No DAC) and Ipamorelin blend is a synergistic combination of two distinct growth hormone secretagogues (GHS) widely utilized in *in-vitro* studies to examine complex endocrine signaling pathways. CJC-1295 (No DAC), also known as Modified GRF (1-29), is a synthetic analog of endogenous Growth Hormone Releasing Hormone (GHRH). It functions by binding to the GHRH receptors on pituitary somatotropes, stimulating the production and release of growth hormone. Ipamorelin, a selective pentapeptide, acts as a potent agonist of the ghrelin/Growth Hormone Secretagogue Receptor (GHSR). By targeting two separate receptor populations concurrently, research suggests this combination produces a complementary signaling effect, leading to a more robust pulsatile release of GH than either compound alone, without significantly impacting prolactin or cortisol levels in laboratory models. In preclinical research environments, this peptide blend is primarily investigated for its impact on cellular metabolism, protein synthesis, and tissue regeneration markers. Scientists utilize the blend to study the downstream effects of elevated IGF-1 (Insulin-like Growth Factor 1) expression in various cell lines. Unlike the "DAC" (Drug Affinity Complex) version of CJC-1295, which provides a long-acting, continuous elevation of hormone levels, the "No DAC" variant exhibits a much shorter half-life. This allows researchers to simulate more natural, pulsatile physiological rhythms in experimental models. Current research applications also include investigating the role of GHSR activation in cytoprotection, bone mineral density modulation, and lipid metabolism within strictly controlled laboratory settings. **Reconstitution and Storage Guidelines** To maintain the structural integrity and bioactivity of the CJC-1295 / Ipamorelin blend, rigorous handling protocols must be observed. The lyophilized powder should be stored at -20°C for long-term stability. For experimental use, reconstitution should be performed using bacteriostatic water or sterile physiological saline, avoiding vigorous mechanical agitation; gentle swirling is recommended to prevent peptide shearing. Once reconstituted, the solution is highly sensitive to temperature and light; it should be stored at 2°C to 8°C and utilized within a timeframe consistent with the laboratory’s specific stability testing. Repeated freeze-thaw cycles should be avoided as they may lead to peptide degradation and compromised experimental results. *** **WARNING:** This product is intended for **IN-VITRO LABORATORY RESEARCH USE ONLY.** It is not for human or veterinary use. All research must be conducted by qualified professionals in a controlled environment.